| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.00068 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.00089 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.0003 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.00022 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00024 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.00021 | 1 |